1000005661

Morepen Lab.

56.80
+0.05 (0.09%) NSE

Last updated on 29 Dec 2021 10:12 AM

Returns
9.34%
Loading chart...

Fundamentals

Large Cap

Financial - Banking

Market Cap (Cr)

3176.88

Earning Per Share

2.1

Dividend Yield

-%

P/E Ratio

15.31

P/B Ratio

5.98

Debt to Equity

0.38

Performance

min-value
max-value

Open

56,601.30

52-wk High

75,250.00

High

56,601.30

52-wk Low

75,250.00

Low

56,601.30

Band

75,250.00

Lower Circuit

56,601.30

Upper Circuit

75,250.00

Volume

56,601.30

VWAP

75,250.00

52 Week Performance

min-value
max-value

5.34% down side

up side5.34%


About the company

Morepen Laboratories Limited is an India-based pharmaceutical company. Its products include Loratadine, Montelukast Sodium, Atorvastatin Calcium and Sultamicillin. The company markets formulation products in various therapeutic categories, such as antibiotics, gastrointestinal, respiratory, analgesic, antiallergic and neuropsychiatry with brands, such as Saltum, Saltumax, Cefpopen, Cefpen-S, Dom-DT, Acifix, Rabipen- DSR and Montelast. It has new products added to the therapeutic categories, including Kilbac, Ducal D, Aclomore and Montelast-L. The company has three state-of-the-art manufacturing plants in the northern state of Himachal Pradesh (HP) in India.

Similar Companies